Xiaolu Biomedicine

BiotechnologyAngelSuzhou, China

Latest round

Angel

Last raised

Apr 2025

Total raised

Undisclosed

Investors

8

About Xiaolu Biomedicine

Based in Suzhou, China, and founded in 2025, Xiaolu Biomedicine operates as a biopharmaceuticals developer that focuses on the development of large molecule antibody drug. Xiaolu Biomedicine focuses on the research and development of large molecule antibody drugs in the field of autoimmune and inflammatory diseases. The company has independently developed an antibody technology platform to develop a new generation of drugs by finding targets and target combinations based on pathogenic mechanisms. The company generates revenue by developing and providing innovative medicines for autoimmune and inflammatory diseases.

Who invested in Xiaolu Biomedicine

8 investors across 1 round

See all investors in Xiaolu Biomedicine

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Apr 22, 2025

    Amount

    Undisclosed

    Investors

    Locked

Questions about Xiaolu Biomedicine

Who invested in Xiaolu Biomedicine?

Xiaolu Biomedicine has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Xiaolu Biomedicine raised?

Xiaolu Biomedicine has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Xiaolu Biomedicine last raise money?

Xiaolu Biomedicine's most recent round on record is a Angel, in Apr 2025.

What does Xiaolu Biomedicine do?

Based in Suzhou, China, and founded in 2025, Xiaolu Biomedicine operates as a biopharmaceuticals developer that focuses on the development of large molecule antibody drug.

Where is Xiaolu Biomedicine headquartered?

Xiaolu Biomedicine is headquartered in Suzhou, China.

Which VCs invest in companies like Xiaolu Biomedicine?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Xiaolu Biomedicine's stage. Their profiles are linked below.

Raising like Xiaolu Biomedicine? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.